Durur-Subasi, I. Et Al. 2021. Does the cardiovascular drug levosimendan prevent iodinated contrast medium nephrotoxicity with glycerol aggravation in rats?. EUROPEAN RADIOLOGY EXPERIMENTAL , vol.5, no.1 .

Durur-Subasi, I., KÖSE, D., YAYLA, M., Sirin, B., KARAMAN, A., ÇALIK, İ., ... ALPER, F.(2021). Does the cardiovascular drug levosimendan prevent iodinated contrast medium nephrotoxicity with glycerol aggravation in rats?. EUROPEAN RADIOLOGY EXPERIMENTAL , vol.5, no.1.

Durur-Subasi, IRMAK Et Al. "Does the cardiovascular drug levosimendan prevent iodinated contrast medium nephrotoxicity with glycerol aggravation in rats?," EUROPEAN RADIOLOGY EXPERIMENTAL , vol.5, no.1, 2021

Durur-Subasi, IRMAK D. Et Al. "Does the cardiovascular drug levosimendan prevent iodinated contrast medium nephrotoxicity with glycerol aggravation in rats?." EUROPEAN RADIOLOGY EXPERIMENTAL , vol.5, no.1, 2021

Durur-Subasi, I. Et Al. (2021) . "Does the cardiovascular drug levosimendan prevent iodinated contrast medium nephrotoxicity with glycerol aggravation in rats?." EUROPEAN RADIOLOGY EXPERIMENTAL , vol.5, no.1.

@article{article, author={IRMAK DURUR SUBAŞI Et Al. }, title={Does the cardiovascular drug levosimendan prevent iodinated contrast medium nephrotoxicity with glycerol aggravation in rats?}, journal={EUROPEAN RADIOLOGY EXPERIMENTAL}, year=2021}